Skip to main content
Log in

Increasing efficiency of MRE for diagnosis of Crohn’s disease activity through proper sequence selection: a practical approach for clinical trials

  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

Purpose

To derive the best magnetic resonance enterography (MRE) approach for detecting activity and severe lesions in Crohn’s disease (CD) to use for selecting patients and measuring response to treatment in clinical trials.

Methods

We compared the accuracies of MRE (T2-weighted sequences, DWI (b = 800 s/mm2) sequences, combined T2-weighted and DWI sequences, combined T2-weighted or DWI sequences, and MaRIA score based on T2-weighted and contrast-enhanced T1-weighted sequences) versus ileocolonoscopy (SES-CD) performed within 1 month. Bowel segments were classified as inactive (SES-CD < 2), active (SES-CD ≥ 2), or active with severe lesions (ulcers seen at endoscopy). McNemar’s test was used to compare the accuracies of the different approaches against endoscopy.

Results

224 segments in 43 patients were analyzed. For detecting active disease, the combination of findings from T2 and DWI sequences results in the highest specific and accurate sequence combination. Combined T2-weighted and DWI sequences had similar sensitivity to those of MaRIA (P = 0.25) but lower specificity (P = 0.007) and accuracy (P = 0.0013) than MaRIA score. For detecting severe lesions, T2-weighted sequences alone had greater accuracy [similar to MaRIA score (P > 0.999)] than other noncontrast approaches.

Conclusions

T2-weighted sequences should be used as a first screening step, and followed by contrast-enhanced T1-weighted sequences only when abnormal findings are identified; adding DWI does not improve the accuracy of MRE.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

CD:

Crohn’s disease

DWI:

Diffusion-weighted imaging

MRE:

Magnetic resonance enterography

CI:

Confidence interval

SES-CD:

Simplified endoscopic score for Crohn disease

Anti-TNF:

Anti-tumor necrosis factor

References

  1. Peyrin-Biroulet L, Reinisch W, Colombel J-F, et al. (2014) Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn’s disease in the SONIC trial. Gut 63:88–95

    Article  PubMed  Google Scholar 

  2. Jauregui-Amezaga A, Rimola J, Ordás I, et al. (2015) Value of endoscopy and MRI for predicting intestinal surgery in patients with Crohn’s disease in the era of biologics. Gut 64:1397–1402

    Article  CAS  PubMed  Google Scholar 

  3. Coimbra AJF, Rimola J, O’Byrne S, et al. (2016) Magnetic resonance enterography is feasible and reliable in multicenter clinical trials in patients with Crohn’s disease, and may help select subjects with active inflammation. Aliment Pharmacol Ther 43:61–72

    Article  CAS  PubMed  Google Scholar 

  4. Panes J, Bouhnik Y, Reinisch W, et al. (2013) Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. J Crohns Colitis 7:556–585

    Article  CAS  PubMed  Google Scholar 

  5. Horsthuis K, Bipat S, Bennink RJ, Stoker J (2008) Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: meta- analysis of prospective studies. Radiology 247:64–79

    Article  PubMed  Google Scholar 

  6. Panés J, Bouzas R, Chaparro M, et al. (2011) Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn’s disease. Aliment Pharmacol Ther 34:125–145

    Article  PubMed  Google Scholar 

  7. ACR Committe on Drgs and Contrast Media (2015) ACR manual on contrast media version 10.1. ACR

  8. Seo N, Park SH, Kim K-J, et al. (2016) MR Enterography for the evaluation of small-bowel inflammation in Crohn disease by using diffusion- weighted Imaging without intravenous contrast material: a prospective noninferiority study. Radiology 278:762–772

    Article  PubMed  Google Scholar 

  9. Choi SH, Kim KW, Lee JY, Kim K, Park SH (2016) Diffusion-weighted magnetic resonance enterography for evaluating bowel inflammation in Crohn ’ s disease : a systematic. Inflamm Bowel Dis 22:669–679

    Article  PubMed  Google Scholar 

  10. Oussalah A, Laurent V, Bruot O, et al. (2010) Diffusion-weighted magnetic resonance without bowel preparation for detecting colonic inflammation in inflammatory bowel disease. Gut 59:1056–1065

    Article  PubMed  Google Scholar 

  11. Kim K-J, Lee Y, Park SH, et al. (2015) Diffusion-weighted MR enterography for evaluating Crohn’s disease: how does it add diagnostically to conventional MR enterography? Inflamm Bowel Dis 21:101–109

    Article  CAS  PubMed  Google Scholar 

  12. Harvey RF, Bradshaw JM (1980) A simple index of Crohn’s-disease activity. Lancet 1:514

    Article  CAS  PubMed  Google Scholar 

  13. Daperno M, D’Haens G, Van Assche G, et al. (2004) Development and validation of a new, simplified endoscopic activity score for Crohn’s disease: the SES-CD. Gastrointest Endosc 60:505–512

    Article  PubMed  Google Scholar 

  14. Rimola J, Rodriguez S, Garcia-Bosch O, et al. (2009) Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn’s disease. Gut 58:1113–1120

    Article  CAS  PubMed  Google Scholar 

  15. Rimola J, Ordás I, Rodriguez S, et al. (2011) Magnetic resonance imaging for evaluation of Crohn's disease. Inflamm Bowel Dis 17:1759–1768

    Article  PubMed  Google Scholar 

  16. Steward MJ, Punwani S, Proctor I, et al. (2012) Non-perforating small bowel Crohn’s disease assessed by MRI enterography: derivation and histopathological validation of an MR-based activity index. Eur J Radiol 81:2080–2088

    Article  PubMed  Google Scholar 

  17. Dohan A, Taylor S, Hoeffel C, et al. (2016) Diffusion-weighted MRI in Crohn ’ s disease: current status and recommendations. J Magn Reson Imaging 44:1381–1396

    Article  PubMed  Google Scholar 

  18. Maccioni F, Bruni A, Viscido A, Colaiacomo MC, Cocco A (2006) MR imaging in patients with Crohn disease : value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent. Radiology 238:517–530

    Article  PubMed  Google Scholar 

  19. Sato H, Tamura C, Narimatsu K, et al. (2015) Magnetic resonance enterocolonography in detecting erosion and redness in intestinal mucosa of patients with Crohn’s disease. J Gastroenterol Hepatol 30:667–673

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jordi Rimola.

Ethics declarations

Conflict of interest

Authors have nothing to disclose.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 98 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rimola, J., Alvarez-Cofiño, A., Pérez-Jeldres, T. et al. Increasing efficiency of MRE for diagnosis of Crohn’s disease activity through proper sequence selection: a practical approach for clinical trials. Abdom Radiol 42, 2783–2791 (2017). https://doi.org/10.1007/s00261-017-1203-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-017-1203-7

Keywords

Navigation